Virax Biolabs Group Ltd. (VRAX)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 79
-0.11
-2.8205%
$
697.98K Market Cap
- P/E Ratio
- Div Yield
405,100 Volume
0 Eps
$ 3.9
Previous Close Want to track VRAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Virax Biolabs Group Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Anthony Scaramucci SkyBridge Capital II LLC | 35,152.12 | $193,266.36 | $122,072.77 | -$71,193.59 | -36.84% |
 Christopher C. Powers Farther Finance Advisors, LLC | 0.84 | $13 | $3.18 | -$9.82 | -75.54% |
